{"name":"OnKure, Inc.","slug":"onkure-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":48260000,"netIncome":-59517000,"cash":59050000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2024"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPVUpUUTU3Um53dnQ4dnc2bTJSOXduYXBDV1RyS1FiVmR6endtWklHU2xrMVdhbnRYT0FNdWh4Zi03d0FnRTdsSlk1TndkRld4c1o4Rks4V2Y5S0xIbWhudjFkRnRUdUlqbkhhZjJQeUFobjgyUEJaOEt0c0pNeG8zb3RNUlgyeGxzUXl5RklR?oc=5","date":"2026-03-27","type":"pipeline","source":"BizWest","summary":"OnKure to sell $150M in stock to fund drug development - BizWest","headline":"OnKure to sell $150M in stock to fund drug development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNOEJWVEdZM09HM2Exb0ZoNTlDM09xMVVCRGQzS2kyYk4zMWlXd1l4b2llZjRyT1lBcm5leFV1dkZsWm9VbDJXUXJNdXcwemM0UjVzWTRTX1V3eXF6X3BXbjhNLXVHNXNEVjVsSkRqVUFZaUtzX2lFeXdjbVhFYmVOa3NuV3E?oc=5","date":"2026-03-26","type":"pipeline","source":"Crunchbase","summary":"Access Biotechnology - Financial Details - Crunchbase","headline":"Access Biotechnology - Financial Details","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB0bFZiVHAtVW5QcTdCSmtNZWxjRkRZQzZhVXBsSHBuazlHME1JZW1SR1dwSDVfamwxWnpseVBuaVozTnlCRU9XelJwNHhLU2kyQk9JYWVEd3Bpb2F6dXdrWVhuRkN4TE54V3lDNjRR?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in OnKure Therapeutics (OKUR) - Stock Titan","headline":"If You Invested $1,000 in OnKure Therapeutics (OKUR)","sentiment":"neutral"},{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNMzdrNXZFeXROWFBOelkzZmpzN2U2TXdrRjFjcW5QcVpPS0FBUmF6Q3dQUGlQdVJNOWprdWlGVTRVMmxOZGhPVUFaUDYxRlFnYjZKWTRuVjNhZmlFZmNMd3pDcy1qeVlWRkdtVFNSY3N2Tkl4TVVOdmN2SExMeW14R0g5eWRUaXJ3Sy1fZm5NLWFtbXJPdnotbFJnNXhjX2I2UWZveEdvN2lycGZxc01CZktSeElOOENITFpBOXpOV0ZhWWJfUjFEczJRQ2J1VDRVTGQzZDBMZ19ZaVBKWldoX2JJekY3Y0dI0gHuAUFVX3lxTE1DYlhYS3VWVnl2YnU2Q0syRXFzaS02VmVydkRoZWpQNElydTFZSjFjbm91LTFXUzVrUV8ydEY2WHBxaHZLaHQ2VS1IQkhPaWNNbktFRmdzLVFVSEQ0V3h5eVNtS1NkZDRFWGNEUlY3MXhobVJMbnIybVFWVGtvMXdFd0F2cVlXY0tIM2tOVERlYU10Q2d0WlM2cFdpWFZvRjkzRmZEaUdiU1YycXdiRWJVbW1NRXM0eWlsWVZ5b25od1hudnpZSDZYbDQ2b2xFb1ZtbWpSdnBwcVhHZ2FySksyTnlZVXM1SFlYbnZDR0E?oc=5","date":"2025-07-23","type":"pipeline","source":"simplywall.st","summary":"Is OnKure Therapeutics (NASDAQ:OKUR) In A Good Position To Deliver On Growth Plans? - simplywall.st","headline":"Is OnKure Therapeutics (NASDAQ:OKUR) In A Good Position To Deliver On Growth Plans?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPOWwzT2M5Ui1zdnY3THJMcGVHSk5nNXc5X1RDVUEtNHhRT2lDSEtWaHZrTG1xdkJKZjdqMTFoSEhxd3VOY1RNa1J3dThuQWtjRC1td1NLODFiVjY1NGtHWDZxZmNUZ2xXZy1zOXVUT21hTVdfSEdra2xtMmo0clR5VjhCUk1IbnJjM1JBWXZMRmt3X3NCMVBUR3gzUmFKSVluOGlqQjloRVVoR0pyd29oLWNkcmd5aFVX?oc=5","date":"2024-10-24","type":"pipeline","source":"Seeking Alpha","summary":"OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond (OKUR) - Seeking Alpha","headline":"OnKure: Looking To Alter PI3K Inhibitor Targeting In Breast Cancer And Beyond (OKUR)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQcVZLdkNsX0JaVlEzNVRtWFo3WWVmaUo4dlRJc1FkTTFVR0tQN3JhWkNrTTg2eGpURE9JdU1XWDZiUk9Sd3B5eTY3ci0xdlZKSEVzdmptcTF4TjVSRFprY1NqS2Z2Y215bzhRZEQ5dTI5M2hqT0xRUC14YWJZMnoycjA2NGlpUVI2TEpz?oc=5","date":"2024-10-07","type":"deal","source":"Pharmaceutical Technology","summary":"OnKure and Reneo Pharmaceuticals complete merger - Pharmaceutical Technology","headline":"OnKure and Reneo Pharmaceuticals complete merger","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQcWEyRFpBR0pMVGp3YzdjdElncmp1WndJc01lYi1DOEUwRVN2THBLSXN3bkMxRllYR05STHRuYXlmVUhpN3pRZWFzOVdqTzFvbmJfNXNTNkoxUXN5WTJWdUZTMlFiY3JNR2VZUms1REVPd1VmcUVWVWlwTnlhNUE1Wk4wS3Zyc1NGSUxaOGRldi04V2J2TlZCQVN0RGFxeUg2YWtueGwyM2lWTEJ4NW5ETDhXNi1fRHBoeGx6Vkl6STZHbTZZdVlhTUZodlRRZHRJQ2F0dGc5WGFxdWZKbEdFNExja01NVElOVmlENEhEcGJWYlp2VUJUNWZPcWI3RHMwQXFsR2VHZFlyczJV?oc=5","date":"2024-10-04","type":"deal","source":"GlobeNewswire","summary":"OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million - GlobeNewswire","headline":"OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPM0NSU0JlR1MzR1YxakRYdXc5aVdKa3B6aTh2UkZOdG9YM3VJa3V2V19TUUNTS2hyV1Q0ZTQ2M2RzOGlDQkxEQ1ZNazBNX3RVdmlXemRPMmE2djFuNHJYMVN5dTA5cGJfWU11ejJDNk4wVlRnbzVTbGdxOFlsWW9uVWxlYnREMU1meFBnanRLXzBmSkFOOGdIb0JpN3VsZU0?oc=5","date":"2024-10-02","type":"regulatory","source":"Yahoo Finance","summary":"Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure - Yahoo Finance","headline":"Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQaXdvajU1ZjVGMy1FUk9DazNvY09XZUh4N3FYM0lod0lLUUZPenpCbGtYaFJjWF9BeElYMDF1cDgzaXN1dk9ka3RyRkVWelZlY05fN29QOC13WEM2Q1NOWDFKdi1WbGNhZHZWSkJMUWZwUXBsdU1vdjQ5MkpMOTI2TVBzMGw5UjAwTFdFRzlnRTF2VzdO?oc=5","date":"2024-08-13","type":"earnings","source":"Yahoo Finance","summary":"Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results - Yahoo Finance","headline":"Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNdlczZW9HWGdyaFhWT3Z1YWZ1T3diZzRqWC1WWl8tanBwckdMOVNIUldHdEdLd1FPcWtYc2VhWXVtTTVSNXdWS0x6eEhYMFFhN0pybkc2d2lEVUliZlU1YmpLcTRobWJCdTdRMUt0UFAtWERNV1JvVGRKOG9vRVpRTnJSa3BGc1JXc19uYXhR?oc=5","date":"2024-05-13","type":"pipeline","source":"Fierce Biotech","summary":"OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot - Fierce Biotech","headline":"OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQYmFSREJITHVGY0dDSTlXT1JXWTk3NGg2YzdfdndpdG82N201R2w4QUw5ZU9IRXNpdTNIVUxUSmZDVzQ4Qm4ydDdxUm9YbnhIZ0VuRDJsNHNpQUdES2RBYThQRFJHYWFySXF3RUVMb3JsSlJ5Y3ZxUnZ4X2FHZzFzNlNHMktzX3pSS0ZFVllJbXBxMWlIZEg4QlRTU3VmVnllUVJsWFczSjhNbWFDdTRVanNn?oc=5","date":"2024-05-13","type":"trial","source":"BizWest","summary":"With first drug trial underway, OnKure inks merger with Reneo Pharma to go public - BizWest","headline":"With first drug trial underway, OnKure inks merger with Reneo Pharma to go public","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOWlZEWXVLRFNvM212Zm9taExWbGhHblRheW1GYUhiYVQxQ0Y5NWJPQnVHdXVMaTljNG54SWdwOVotcUpQQU1idFp2eDQ2YU9abU03TDdhUXJucHdWd19ReVdXSU9rT05TQUdXc0xTeUkzWjVHdVZQOEFSMlpxaWIxeDRFS3RXZU1DN000V1FvSUZaUkRCUmc?oc=5","date":"2023-05-26","type":"pipeline","source":"The Business Journals","summary":"Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round - The Business Journals","headline":"Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2024-12-31","revenueHistory":[{"value":0,"period":"2024-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":48260000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-59517000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":59050000,"cashHistory":[],"totalAssets":62117000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}